Introduction
To evaluate new therapeutic compounds
Additional culture parameters can be modulated to imitate the physiological cellular environment
Numerous studies have been performed to evaluate the effect of physiological oxygen tension and osmolarity on chondrocyte phenotype and matrix production. It has been demonstrated that lower oxygen tensions in 3D or monolayer culture (1–5% O2) increase the production of cartilage ECM molecule in comparison with cultures at 21% O2.
Only little information is available on the combined effect of hypoxia and physiological cartilage osmolarity on chondrocytes. In one study, several culture conditions were tested on bovine chondrocytes in 3D culture including the combination of 5% versus 21% oxygen with a normal or hypertonic culture medium (390 mOsm).
In this study, we aimed at providing additional insights on the combined effect of oxygen and osmolarity on chondrocytes 3D culture. For this purpose, it was decided to use osmolarity and oxygen conditions at the end of the physiological ranges (3% O2 and 430 mOsm) to maximize the probability to observe significant effects. The goals of this study were (1) to evaluate if the benefit of a physiological oxygen tension and a physiological osmolarity are additive on both the phenotype maintenance and ECM deposition; (2) to investigate if a potential increase of hypertrophy markers owing to the higher osmolarity could be compensated by a low oxygen tension; and (3) to compare the matrix-to-cell ratio and the histological appearance of the obtained 3D constructs to those of native cartilage and determine which culture conditions lead to constructs resembling cartilage the most. To do so, porcine chondrocytes were cultured in 3D scaffold-free culture at 330 (nonadjusted DMEM high glucose [DMEMHG] medium) or 430 mOsm and at 3% or 21% O2 for 5 weeks. Matrix production, phenotype marker expression, and histology analysis were performed.
Materials and Methods
Chondrocyte isolation and culture
Porcine chondrocytes were isolated from the femoral heads of pigs, ∼1 year of age obtained from a local slaughterhouse (Arras, Reichelsheim-Beerfurth). To remove cells from soft tissues, cartilage was digested sequentially with 0.25% w/v collagenase (Cat. No. 17465; Serva GmbH), in HAM's F12 (Cat. No. 21765; Gibco®, Life Technologies) for 45 min at room temperature and 0.1% w/v collagenase in HAM's F12 with 1% penicillin/streptomycin (Gibco®, Life Technologies) overnight at 37°C. The resulting cell suspension was filtered through 100 μm, then 40 μm cell strainers (Becton Dickinson GmbH), washed several times by centrifugation, and resuspended in culture medium. Isolated porcine chondrocytes were then inoculated at 1 × 106 cells/well in 200 μL of medium in an ultra-low binding 96-well plate to allow the cells to aggregate. Half the samples were incubated at 3% O2 and the other half at 21% O2. The medium composed of DMEMHG, 10% fetal calf serum (FCS; Promocell GmbH), 50 μg/mL ascorbate-2-phosphate, and 0.4 mM proline with the osmolarity left unchanged (330 mOsm) or adjusted to 430 mOsm with NaCl. After 1 week, the chondrocytes had condensed to form a stable 3D construct and were transferred in a 24-well plate in 1 mL of the same medium or oxygen tension and were cultured for four additional weeks. At the end of the culture period, the 3D constructs were either used for biochemical analysis (DNA, GAG, and hydroxyproline [HPro] content), gene expression (real-time polymerase chain reaction [PCR]), or histological analysis with
Preparation of porcine cartilage samples
For the measurement of GAG, DNA and HPro in native porcine cartilage four femoral heads from four different animals were used. Four pieces of cartilage (∼5 mm in size) were harvested from each femoral head with a scalpeland digested with papain as described previously.
For the histology of native cartilage, 4 mm explants were taken from a femoral heads and cultured 3 days in DMEMHG with 10% FCS (Gibco®, Life Technologies), 1% penicillin/streptomycin, 2.5 μg/mL amphotericin B (PAN Biotech GmbH), and 50 μg/mL ascorbate-2-phosphate and one additional day in the same medium with FCS before being processed for Safranin O staining as described in the
Biochemical analysis
GAG measurement
A dimethylmethylene blue (DMMB) assay was used to quantify GAG in the papain lysate of the 3D constructs. Fifty microliters of the samples (diluted 1/100 in phosphate-buffered saline [PBS]) were mixed with 200 μL of DMMB reagent in a 96-well plate. The absorbance at 525 nm was compared with that of chondroitin sulfate C standards (C4384 diluted in medium or in PBS; Sigma-Aldrich). The DMMB reagent was composed of 16 mg/L DMMB (Applichem) in 0.5% v/v ethanol, 0.2% formic acid, and 2 g/L sodium formate.
DNA measurement
DNA was measured with the Quant-iT PicoGreen dsDNA assay kit (Life Technologies). Papain lysates were diluted 1/100 in TE buffer. Twenty microliters of the diluted sample was then mixed with 80 μL TE buffer and 100 μL PicoGreen solution in a black 96-well plate. The fluorescence (Em.:485 nm, Exc.: 535 nm) was measured with a fluorescence reader and compared with that of a DNA standard from 31.25 to 1000 ng/mL diluted from the DNA stock solution provided with the PicoGreen kit. From the DNA concentration the number of cells/construct could be calculated.
HPro measurement
The quantitative determination of 4-hydroxyproline was performed using a high-performance liquid chromatography–mass spectrometry/mass spectrometry (HPLC-MS/MS) assay. The stock solution of 4-hydroxyproline (VWR International) was prepared to a concentration of 30 mg/mL in water (Lichrosolv; Merck KGaA) and further diluted to obtain calibration standards ranging from 0.1 to 50.0 μg/mL.
Five microliters of samples was mixed with 10 μL of internal standard (1.2 μg/mL 4-hydroxyproline [
Gene expression
The 3D constructs were placed in a Precellys vial (MK28-R tubes; Bertin Technologies) with 300 μL of RLT buffer (from the RNeasy Mini Kit; Qiagen) and shaken 4 × 1 min at 20 Hz with the Tissue-Lyser (Qiagen). About 590 μL of DEPC-treated water and 10 μL of proteinase K (Qiagen) were then added to the samples and incubated for 10 min at 55°C before being centrifuged 3 min at 10,000
The reverse transcription was realized with the SuperScript III First-Strand Synthesis SuperMix (Invitrogen Corp.). The cDNA was digested by RNAse H to digest RNA and analyzed by quantitative polymerase chain reaction (qPCR) with the SYBRGreen Jumpstart Taq Ready Mix (Sigma-Aldrich) in the presence of the reverse and forward primer at 200 nM each (ordered from Eurofins MWG Operon;
Table 1. List of Primers
Gene | Forward sequence | Reverse sequence |
RPL13A | TACGTTCTTTTCCGCCTGCT | TCAAGGTGGTGCGTCTGAAG |
Type I collagen | CCTACAGGTACCCTGTGTCC | CCCCAGAAGAACTGGTACAT |
Type II collagen | TCTCCAGGTTCTCCTTTCTG | GGATGGGCAGAGGTATAATG |
Aggrecan | GATGCTGCTCAGGTGTGACT | GCTTATGCCTTCCCAGCTAC |
Sox9 | CAGAACTCCGGCTCCTACTA | GGTCTGGTGAGCTGTGTGTA |
Runx2 | GGGAACTGATAGGGTCCTGA | AGTTCCCAAGCATTTCATCC |
Type X collagen | ACCCATTTTCCCCTCTCTTT | AGGAAAACCTGGACAACAGG |
Alkaline phosphatase | CCAAAGGCTTCTTCTTGCTG | TGTACCCGCCAAAGGTAAAG |
For each sample and each gene, the cycle threshold (Ct) was determined and the relative abundance was calculated according to the following formula: , where HKG is the housekeeping gene ribosomal protein L13A (RLP13A) and GOI, gene of interest. The results are presented as the relative mRNA abundance of the target gene compared with the HKG.
Histology
Samples were fixed in 4% (w/v) paraformaldehyde, embedded in paraffin. Five micrometers slices were stained with Safranin O 0.25% v/v and Fast Green 0.1% (v/v). The immunohistochemical detection of type I and II collagens (rabbit anti-collagen II antibody, 1:500, ab34712, Abcam and mouse anti-collagen I antibody, 1:200, ab90395, Abcam) was realized using a fully automated immunohistochemistry stainer (Bond III; Leica). To visualize the positive matrix, “mixed red refine” and “mixed DAB refine” were used for type I and type II collagen, respectively. Images were acquired with a Leica SCN400 slide scanner.
Statistical analysis
Two-way analysis of variance was applied to the data sets using GraphPad Prism software version 7.03 (GraphPad Software, Inc.). Values of
Results
There are many evidences that removing primary cells from their
Effect of physiological oxygen tension or osmolarity on cell proliferation and ECM deposition
The effect on varying oxygen and osmolarity levels on the cell, GAG, and HPro content in the 3D constructs was investigated. The GAG and HPro contents reflect the proteoglycan and collagen content, respectively.
At an oxygen level of 3%, the cell number in the 3D constructs remained unchanged in comparison with the initial seeding density, whereas a significant cell proliferation was measurable at 21% O2 (
FIG. 1. The effect of different oxygen and osmolarity levels on cell proliferation an ECM production. (A) Cell content per 3D construct. The dotted line represents the initial number of seeded cells (1 million). (B) Amount of μg GAG per 3D construct. (C) Amount of μg HPro content per 3D construct. Bars represent the mean of
Table 2. Amount of Glycosaminoglycan and Collagen in ng/cell for the Four Different Culture Conditions
3% O2, 330 mOsm | 3% O2, 430 mOsm | 21%, 330 mOsm | 21%, 430 mOsm | Porcine cartilage |
|
GAG ng/cell | 0.94 ± 0.07 | 0.89 ± 0.1 | 0.18 ± 0.03 | 0.22 ± 0.03 | 1.13 ± 0.34 |
Collagen |
0.38 ± 0.02 | 0.18 ± 0.04 | 0.07 ± 0.01 | 0.04 ± 0.003 | 2.31 ± 0.9 |
aMeasured from four different animals.
bCalculated with a conversion factor of 7.6.
GAG, glycosaminoglycan.
The effect of oxygen tension or osmolarity on the chondrocyte phenotype
Because the stability of the chondrocyte phenotype is of utter importance for the generation of a lifelike
The mRNA levels of the cartilage ECM molecules, type II collagen and aggrecan, the chondrocyte-specific transcription factor Sox9, and the dedifferentiation marker type I collagen were quantified. In addition, the ratio type I collagen/type II collagen expression was calculated.
At low oxygen levels, type I and II collagen and Sox9 expressions were significantly reduced (
FIG. 2. The effect of oxygen and osmolarity on the chondrocyte phenotype. (A) Expression of type I collagen, (B) type II collagen, (C) Sox9, (D) aggrecan, and (E) the ratio type I collagen/type II collagen expression. N.D. indicates that type I collagen expression was not detectable. Bars represent the mean of
On the contrary, at high osmolarity, type I collagen expression and the ratio type I collagen/type II collagen expression were significantly decreased at both 3% and 21% O2 (
To evaluate the matrix composition of the 3D constructs, type I and II collagen and Safranin O/Fast Green stainings were performed. Type II collagen and Safranin O/Fast Green stainings were positive in all culture environments. However, the type II collagen staining seems to be weaker at 3% O2 compared with 21% O2, whereas the contrary was observed at the gene expression level. One possible explanation is that after 5 weeks of culture, when the gene expression analysis was performed, the cells cultured at 3% O2 had already accumulated enough type II collagen to initiate a reduction of their type II collagen expression. On the contrary, a positive staining for type I collagen was only observable in 3D constructs cultured at 330 mOsm (
FIG. 3. The effect of oxygen and osmolarity on ECM composition. Representative images of Safranin O/Fast Green, type I collagen (mixed red refine) and type II collagen (mixed DAB refine) stainings of constructs cultured at 3% or 21% oxygen and 330 or 430 mOsm. Scale bar is 500 μm.
Effect of oxygen tension or osmolarity on hypertrophy markers
To further evaluate the impact of different oxygen and osmolarity levels, the expression of the hypertrophy markers type X collagen, Runx2 and alkaline phosphatase were investigated. Hypertrophy corresponds to the terminal differentiation of chondrocytes leading to ossification and bone formation during development. However, hypertrophy does normally not occur in mature cartilage, except in OA cartilage, leading to cell apoptosis and matrix calcification that is usually not wanted in a 3D chondrocytes culture model.
Type X collagen was not influenced by osmolarity or the oxygen tension (
FIG. 4. Effect of oxygen and osmolarity on hypertrophy markers. (A) Expression of type X collagen, (B) Runx2 and (C) alkaline phosphatase. Bars represent the mean of
Effect of combined high osmolarity and low oxygen on chondrocytes 3D culture
Both a higher osmolarity and a lower oxygen tension were found to have a beneficial effect on the phenotype: Type I collagen expression was decreased and the expression of hypertrophy markers (
There are several ways to evaluate the quality of engineered cartilage and compare it with native cartilage. For this study, two of the most common approaches were selected: the analysis of the biochemical content and of the histological appearance.
Finally, histological slides of porcine cartilage and the 3D constructs are given in
FIG. 5. Native porcine cartilage in comparison with cell constructs cultured in various environments. Representative images of Safranin O/Fast Green stainings of native porcine cartilage and constructs cultured at 3% or 21% oxygen and 330 or 430 mOsm. The arrows show areas devoid of Safranin O staining indicating a reduced matrix content. The inserts show the cell morphology in their matrix.
Discussion
In this study we aimed at evaluating if the combination of a physiological osmolarity together with a physiological oxygen tension could be beneficial for chondrocyte 3D culture. For this purpose, porcine chondrocytes were cultured in 3D at 3% or 21% O2 and at 330 or 430 mOsm for 5 weeks. The cell and matrix content of the 3D constructs and their histological appearance were evaluated and compared with native cartilage. In addition, the expression of phenotypic markers was investigated.
We observed that applying a physiological oxygen tension or a physiological osmolarity and the combination of both influenced the proliferation, phenotype maintenance, and ECM secretion of the chondrocytes. A higher osmolarity (430 versus 330 mOsm) resulted in a reduced HPro content, reduced type I collagen expression, and an increased Sox9 and aggrecan expression. The reduced HPro content is thought to be mainly driven by the decrease of type I collagen expression as type II collagen expression was not influenced by osmolarity. These results are in accordance with previous findings.
Low oxygen resulted in a lower cell content and a decreased type I, type II, and Sox9 expression. However, the overall GAG and HPro content per cell was found to be higher at 3% than at 21% O2. There exists contradictory results in literature regarding matrix production in 3D chondrocytes culture at low oxygen versus ambient oxygen tension
When comparing the effect of lower oxygen and the effect of a higher osmolarity, both had a positive impact on the chondrocyte phenotype as both strongly downregulated type I collagen expression and the type I collagen/type II collagen ratio. Three percent O2 prevented cell proliferation but resulted in an increased matrix production per cell. Regarding the expression of hypertrophy markers, no increase in hypertrophy markers owing to the higher osmolarity, as described previously with ATDC5 or human mesenchymal stem cells,
To our knowledge, only one study evaluating the combination of physiological oxygen tension and osmolarity on the chondrocytes phenotype and ECM production was published. Ylärinne et al.
The results of this study are highly relevant for the tissue engineering field. To test therapeutic compounds, it is of crucial importance to work with differentiated chondrocytes in a cartilage-like environment. This enables to better predict
One of the limitations of this study is that the chondrocytes we used originated from young animals and not adult humans. However, because we observed similar effects of osmolarity and oxygen as those reported in human chondrocytes,
As a conclusion, both physiological osmolarity and oxygen level have a positive effect on the chondrocyte phenotype (decreased expression type I collagen and hypertrophy markers) with the strongest benefit reached with the combination of both (type I collagen expression not detectable anymore). In addition, the use of a physiological oxygen level enables to build chondrocytes-matrix constructs that are the closest to native cartilage regarding the matrix-to-cell ratio.
Author Disclosure Statement
All authors were employees of Merck KGaA at the time of the study.
Abbreviations Used
three dimensional
dimethylmethylene blue
extracellular matrix
fetal calf serum
glycosaminoglycan
gene of interest
housekeeping gene
high-performance liquid chromatography–mass spectrometry/mass spectrometry
hydroxyproline
phosphate-buffered saline
ribosomal protein L13A
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© Stefan Sieber et al. 2020; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons License ( http://creativecommons.org/licenses/by/4.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
Abstract
For cartilage repair
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Osteoarthritis Research, Merck KGaA, Darmstadt, Germany